We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Fundamental aspects
-
1. Inflammation and tissue homeostasis
- Prof. Herman Waldmann
-
2. Introduction to the immune system
- Prof. Herman Waldmann
-
3. Hematopoiesis: the making of an immune system
- Prof. Paul J. Fairchild
-
4. Inflammation: purposes, mechanisms and development
- Prof. Pietro Ghezzi
-
5. Phagocytosis
- Dr. Eileen Uribe-Querol
-
6. Regulated cell death mechanisms and their crosstalk with the immune system 1
- Dr. Luis Alberto Baena-Lopez
-
7. Regulated cell death mechanisms and their crosstalk with the immune system 2
- Dr. Luis Alberto Baena-Lopez
- Innate immunity
-
11. Cells of the innate immune system
- Prof. Kevin Maloy
-
12. Microbial recognition and the immune response
- Dr. Dana Philpott
-
13. Toll-like receptor signalling during infection and inflammation
- Prof. Luke O'Neill
- Intercellular mediators
-
14. Chemokines
- Dr. James E. Pease
-
15. Cytokines
- Prof. Iain McInnes
-
16. IL-1 family cytokines as the canonical DAMPs of the immune system
- Prof. Seamus Martin
-
17. Glycans at the frontiers of inflammation, autoimmunity and cancer
- Prof. Salomé S. Pinho
-
18. Glycoimmunology
- Prof. Paula Videira
- Adaptive immunity B cells
-
21. Antigen recognition in the immune system
- Prof. Herman Waldmann
-
22. B cell biology
- Prof. Richard Cornall
-
23. Antibody structure and function: antibody structure
- Dr. Mike Clark
-
24. Antibody structure and function: antibody function
- Dr. Mike Clark
-
25. Antibody genes and diversity
- Dr. Mike Clark
-
26. In vivo antibody discovery and hybridoma technology
- Prof. Dr. Katja Hanack
-
27. Antibody engineering: beginnings to bispecifics and beyond
- Dr. Ian Wilkinson
-
29. The immunobiology of Fc receptors
- Prof. Mark Cragg
-
30. Immunoreceptors
- Prof. Anton van der Merwe
-
31. Affinity, avidity and kinetics in immune recognition
- Prof. Anton van der Merwe
- Adaptive immunity T cells
-
32. The thymus and T cell development: a primer
- Prof. Georg Holländer
-
33. Lineage decisions in the thymus: T cell lineage commitment
- Prof. Bruno Silva-Santos
-
34. Lineage decisions in the thymus: αβ and γδ T cell lineages
- Prof. Bruno Silva-Santos
-
35. CD4 T cell subsets
- Dr. Brigitta Stockinger
-
36. Cytotoxic T lymphocytes
- Prof. Gillian M. Griffiths
-
37. Gamma delta T-cells
- Prof. Bruno Silva-Santos
-
38. Tfh and Tfr cells
- Prof. Luis Graca
-
39. Tissue resident memory T cells (TRM)
- Dr. Marc Veldhoen
-
40. Mathematical modeling in immunology
- Prof. Ruy M. Ribeiro
- The importance of the MHC in immunity
-
41. The MHC and MHC molecules 1
- Prof. Jim Kaufman
-
42. The MHC and MHC molecules 2
- Prof. Jim Kaufman
-
43. Natural killer cells
- Dr. Philippa Kennedy
-
44. Human NK cells
- Prof. Lorenzo Moretta
-
46. NK cells in viral immunity
- Prof. Lewis Lanier
- Lymphocyte activation
-
47. Signal transduction by leukocyte receptors
- Dr. Omer Dushek
-
48. Immunological memory 1
- Prof. David Gray
-
49. Immunological memory 2
- Prof. David Gray
-
50. Studying immune responses “one cell at a time”
- Dr. Mir-Farzin Mashreghi
- Major cellular partners in immunity
-
51. The mononuclear phagocyte system - tissue resident macrophages: distribution and functions
- Prof. Emeritus Siamon Gordon
-
52. The mononuclear phagocyte system: tissue resident macrophages - activation and regulation
- Prof. Emeritus Siamon Gordon
-
53. Dendritic cells: professional antigen presenting cells
- Prof. Paul J. Fairchild
-
54. Mucosal immunology
- Prof. Daniel Mucida
- Immunological tolerance and regulation
-
55. Self-tolerance
- Prof. Herman Waldmann
-
56. Tolerance and autoimmunity
- Prof. Emerita Anne Cooke
-
57. The balance between intestinal immune homeostasis and inflammation
- Prof. Dr. Janneke Samsom
- Translational immunology - immune deficiency
-
58. Primary immunodeficiency disorders
- Dr. Smita Y. Patel
-
59. Changes in innate and adaptive immunity during human ageing 1
- Dr. Roel De Maeyer
-
60. Changes in innate and adaptive immunity during human ageing 2
- Dr. Roel De Maeyer
-
61. The aging immune system
- Prof. Ana Caetano
- Translational immunology - protection against pathogenic microbes
-
62. Immune responses to viruses
- Prof. Paul Klenerman
-
63. HIV and the immune system
- Prof. Quentin Sattentau
-
64. COVID-19: the anti-viral immune response
- Prof. Danny Altmann
-
65. Bacterial immunity
- Prof. Thomas S. Wilkinson
-
66. Bacterial immune evasion
- Prof. Christoph Tang
-
67. The immunology underlying tuberculosis
- Prof. Thomas R. Hawn
-
68. Innate immunity to fungi
- Prof. Gordon D. Brown
-
69. Adaptive fungal immunity
- Dr. Michail Lionakis
-
70. Parasite immunity: introduction and Plasmodium
- Dr. Catarina Gadelha
-
71. Parasite immunity: Leishmania and Schistosoma
- Dr. Catarina Gadelha
-
72. Vaccination
- Dr. Anita Milicic
-
73. The history of vaccines 1
- Prof. Emeritus Anthony R. Rees
-
74. The history of vaccines 2
- Prof. Emeritus Anthony R. Rees
-
75. The history of vaccines 3
- Prof. Emeritus Anthony R. Rees
-
76. The science of vaccine adjuvants
- Dr. Derek O'Hagan
- Translational immunology - hypersensitivity, autoimmune disease and their management
-
77. Hypersensitivity diseases: type 1 hypersensitivity
- Prof. Herman Waldmann
-
78. Innate lymphoid cells in allergy
- Prof. Emeritus Shigeo Koyasu
-
79. Hypersensitivity diseases: type II-IV hypersensitivity
- Prof. Sara Marshall
-
80. Immune memory underlying lifelong peanut allergy
- Dr. Kelly Bruton
-
81. Memory B cells in allergy: B cell activation and response
- Dr. Kelly Bruton
-
82. Memory B cells in allergy: ontogeny, phenotype and plasticity
- Dr. Kelly Bruton
-
83. B cells at the crossroads of autoimmune diseases
- Dr. Xiang Lin
-
84. Interleukin-17: from clone to clinic
- Prof. Leonie Taams
-
85. Autoimmunity and type 1 diabetes
- Prof. Emerita Anne Cooke
-
86. What is new in type 1 diabetes?
- Prof. Åke Lernmark
-
87. Antibodies to control or prevent type 1 diabetes
- Dr. Robert Hilbrands
-
88. Monoclonal antibodies in haemato-oncology
- Prof. Mark Cragg
-
89. Therapeutic antibodies
- Dr. Geoffrey Hale
-
90. Endothelial cells: regulators of autoimmune-neuroinflammation
- Dr. Laure Garnier
-
91. Neuroimmunometabolism
- Prof. Ana Domingos
-
92. The immunology of multiple sclerosis
- Dr. Joanne Jones
-
94. Ocular immunology: an overview of immune mechanisms operating in the eye
- Dr. Eleftherios Agorogiannis
-
95. Understanding myasthenia gravis and advances in its management
- Prof. Henry J. Kaminski
-
96. The immunology underlying rheumatic diseases
- Dr. Hussein Al-Mossawi
-
98. Complement and lupus
- Prof. Marina Botto
-
99. Immune mechanisms in liver diseases
- Prof. Paul Klenerman
- Translational immunology - transplantation immunology
-
100. Principles of transplantation: overview of the immune response
- Prof. Emerita Kathryn Wood
-
101. Factors influencing outcomes in clinical transplantation 1
- Prof. Emerita Kathryn Wood
-
102. Factors influencing outcomes in clinical transplantation 2
- Prof. Emerita Kathryn Wood
- Translational immunology - cancer immunology
-
103. Cancer immunology
- Prof. Tim Elliott
-
104. Cancer immunotherapy
- Prof. Tim Elliott
-
105. Myeloid-derived suppressor cells in cancer
- Prof. Dmitry Gabrilovich
-
106. IL-2 in the immunotherapy of autoimmunity and cancer
- Prof. Thomas Malek
-
107. Latest advances in the development of CAR & TCR T-cell treatments for solid tumours
- Dr. Else Marit Inderberg
Printable Handouts
Navigable Slide Index
- Introduction
- Contents/agenda
- Synergies with other HS lectures
- Bacteria and disease
- Humans live with and respond to bacteria
- Immune responses to bacteria
- Basic rules to understand the immune response to bacteria
- Major immune mechanisms against extracellular and intracellular bacteria
- Barriers
- Epithelial cells: the key barrier cell
- Innate immunity: players in bacterial immunity
- Innate immunity: pattern recognition families
- Innate immunity: pattern recognition examples
- Innate immunity: phagocytes
- Innate immunity: complement
- Innate immunity: cytokines and chemokines
- Innate immunity: alarmins
- Adaptive immunity (1)
- Adaptive immunity: pathways for dendritic cell (DC) sampling
- Adaptive immunity (2)
- Adaptive immunity (3)
- Adaptive immunity: remember
- Body compartments
- Differentiating commensals and pathogens
- Commensals enhance barriers
- Commensals enhance innate immunity
- Commensals enhance adaptive immunity
- Commensals induce changes in cytokine networks
- Specific examples of immunity to bacterial pathogens
- Specific examples: immunity to E. coli
- Specific examples: immunity to S. aureus
- Specific examples: immunity to Campylobacter
- Specific examples: immunity to Mycobacteria tuberculosis (1)
- Specific examples: immunity to Mycobacteria tuberculosis (2)
- Specific examples: immunity to Chlamydia trachomatis (1)
- Specific examples: immunity to Chlamydia trachomatis (2)
- Summary of factors affecting protective immunity to bacteria
- Acknowledgements and financial disclosures
Topics Covered
- Commensal and pathogenic bacteria
- Three layers of defense bacterial disease
- Mechanism of immunity
- Barrier
- Health promoting commensals
- Cytokine networks
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Wilkinson, T.S. (2025, December 31). Bacterial immunity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved January 1, 2026, from https://doi.org/10.69645/ACMA2254.Export Citation (RIS)
Publication History
- Published on December 31, 2025
Financial Disclosures
- There are no commercial/financial matters to disclose.
A selection of talks on Infectious Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
Let me welcome you to this
talk on bacterial immunity.
I'm Thomas Wilkinson.
I'm a professor of barrier
immunity and infectious disease
at Swansea University
Medical School in the UK.
0:13
We will discuss
bacterial immunity
by focusing on seven
key points shown here.
Firstly, we'll focus on
the importance of bacteria
and bacterial disease,
and then confirm the
basic rules to understand
immune responses to bacteria.
We will refresh knowledge
on the immune response
in three phases and focus on
important players to
defend against bacteria.
We organise the
immune response into
barriers, innate immunity
and adaptive immunity.
Then we will study and
compare examples of
immune responses to
bacterial commensals
and immune responses to
bacterial pathogens.
Finally, we will
end with a summary,
and provide disclosures
and acknowledgements.
0:53
Before we start,
it's also important
to confirm that this
talk is part of
a larger collection of talks
by experts across
all disciplines.
But I draw attention to
the biomedical and life
sciences collection,
and within the microbiology
and immunology sets.
1:09
Bacteria remain a
substantial cause of
mortality and morbidity
across the globe.
As an example, the global
burden of disease studies
have calculated
global estimates of
death due to
bacterial pathogens.
The study confirmed
that 7.7 million deaths
are attributable to 33
bacterial pathogens.
The key infections they cause
are lower respiratory
infections,
bloodstream infections and
intra-abdominal infections
of the 11 syndromes studied.
The five major pathogens
identified were:
Staphylococcus aureus,
Klebsiella pneumoniae,
Escherichia coli,
Pseudomonas aeruginosa
and Streptococcus pneumoniae.
But we should not forget
Mycobacterium tuberculosis,
which wasn't studied and
already has a global
strategy in place.